Professor Moshe Inbar
Modern treatment of breast cancer, immunotherapy breast cancer, immunological treatment, precision medicine, precision (personalized) treatment of breast cancer, clinical oncology, breast cancer, radiation therapy.
Head of Oncology Department, Ichilov, Sourasky Medical Center, Tel Aviv.
Expertise: clinical oncology, breast cancer, radiation therapy.
♦ Medical School, Hebrew University, Jerusalem (1978).
♦ Specialization in Oncology, Ichilov, Sourasky Medical Center, Tel Aviv.
♦ Senior physician, oncology department, Sourasky Medical Center, Tel Aviv.
♦ First Deputy Director of the Department, Cancer Department, Tel Aviv Medical Center.
♦ Head of Chemotherapy Department, Sourasky Medical Center, Tel Aviv.
♦ Director of Oncology Department, Sourasky Medical Center, Tel Aviv.
Research activities and membership in professional organizations:
Since 1998 – member of the Scientific Committee of CECOG.
Since 2002 – the National Council for the Prevention, Diagnosis and Treatment of Malignant Diseases.
2005-2010 – Member of the Academic Council Committee.
2000-2008 – Israel Medical Association of Clinical Oncology and Radiotherapy (IMA).
Chairman of the Israel Association of Clinical Oncology and Radiotherapy.
2002- 2005 – Chairman of Scientific Council Committee for Diagnosis of Breast Cancer IMA.
Since 1973 – Israeli Medical Association.
1988-1992 – Chairman of Israel Society of Clinical Oncology and Radiotherapy.
1989 – American Society of Clinical Oncology (ASCO).
1990 – European Society of Oncology (ESMO).
1991 – European Society of Mastology (EUSOMA).
1999 – Israeli Community for Breast Cancer.
2000-2008 – Chairman of the Israeli Breast Cancer Society (IBCG).
Professor Inbar is a well-deserved member of the Committee on International Protocols in treatment of breast cancer and the author of more than 100 publications as well.